As indicated by the Federation of Indian Chambers of Commerce and Industry (FICCI), all inclusive, India positions third for pharma producing volume and fourteenth as far as esteem.
In itself India speaks
to a noteworthy market for pharma organizations with a populace of more than
1.2 billion yet the nation posts a great fare turnover of over US$10 billion,
spread crosswise over 200 nations. Residential and universal pharma organizations, in any case, confront various significant issues, including drug
quality, clinical trial quality and patent security...( Read More )
www.cooperpharma.com
www.cooperpharma.com
Comments
Post a Comment